Objective To summarize available peer-reviewed literature to describe the range and rate of
complications related to osseointegrated hearing aids in adult and pediatric patients …

Background In July 2018 the active transcutaneous bone conduction hearing implant
received FDA approval in the US (for patients 12 years and older with conductive and/or …

Objective This study assesses soft tissue reactions and implant stability of 1,132
percutaneous titanium implants (970 patients) for bone conduction devices (BCDs). In …

Introduction Bone conduction implants are indicated for patients with conductive and mixed
hearing loss, as well as for patients with single-sided deafness (SSD). The transcutaneous …

The objective of this study is to evaluate the safety and efficacy of a new transcutaneous
bone-conduction implant (BCI BB) in patients with conductive and mixed hearing loss or with …

Purpose Aim of the study was to evaluate the surgical, clinical and audiological outcome of
32 implantations of the Bonebridge, a semi-implantable transcutaneous active bone …

Objective: To assess the benefits of a new type of hearing aid using cartilage conduction
(CC) in patients with severe conduction hearing loss and evaluate its potential for practical …

Objective: To investigate skin-related postoperative complications from tissue preservation
approaches in percutaneous bone conduction device (BCD) implantations. Data Sources …

Bone-conduction implants are a standard therapeutic option for patients with conductive,
unilateral, or mixed hearing loss who either do not tolerate conventional hearing aids or can …

Objectives/Hypothesis The aim of this study was to establish the sound transmission
characteristics of cartilage conduction proposed by Hosoi (2004), which is available by a …